Clinical uses of dexmedetomidine in pediatric patients

Pediatric Drugs

Volumn 10, Issue 1, 2008, Pages 49-69

  Phan, Hanna ^a,b   Nahata, Milap C ^a,b,c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Adolescents; Anaesthesia; Burns, treatment; Cardiovascular disorders, treatment; Children; Delirium, prevention; Dexmedetomidine, pharmacodynamics; Dexmedetomidine, pharmacokinetics; Dexmedetomidine, therapeutic use; Sedation; Shivering, prevention

Indexed keywords

BENZODIAZEPINE; CLONIDINE; DESFLURANE; DEXMEDETOMIDINE; FENTANYL; KETAMINE; LORAZEPAM; MIDAZOLAM; MORPHINE; OPIATE; PARACETAMOL; PENTOBARBITAL; PROPOFOL; ROPIVACAINE; SEVOFLURANE;

AGITATION; ANALGESIA; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BRADYCARDIA; BREATHING RATE; CLINICAL TRIAL; CONTINUOUS INFUSION; CYTOMEGALOVIRUS INFECTION; DELIRIUM; DRUG APPROVAL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG HALF LIFE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HEART CATHETERIZATION; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHERMIA; INTENSIVE CARE UNIT; LARYNX SPASM; LIVER FAILURE; LOADING DRUG DOSE; MEAN ARTERIAL PRESSURE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF LABEL DRUG USE; PEDIATRICS; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SINUS ARRHYTHMIA; TREATMENT DURATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; META-ANALYSIS AS TOPIC; TREATMENT OUTCOME;

EID: 37549068544     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200810010-00006     Document Type: Review

References (61)

1. Tobias JD. Sedation and analgesia in paediatric intensive care units: a guide to drug selection and use. Paediatr Drugs 1999; 1: 109-26
2. Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy 2005; 25 (5): 8S-18S
3. Okamoto MP, Kawaguchi DL, Amin AN. Evaluation of propofol infusion syndrome in pediatric intensive care. Am J Health Syst Pharm 2003; 60: 2007-14
4. Yanay O, Brogan TV, Martin LD. Continuous pentobarbital infusion in children is associated with high rates of complications. J Crit Care 2004; 19: 174-8
5. Malviya S, Voepel-Lewis T, Tait AR, et al. Pentobarbital vs. chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatr Anesth 2004; 14: 589-95
6. Yorgin PD, Theodorou AA, Al-Uzri A, et al. Propylene glycol-induced proximal renal tubular cell injury. Am J Kidney Dis 1997; 30: 134-9
7. Chilcella M, Jansen P, Parthiban A, et al. Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Crit Care Med 2002; 30: 2752-6
8. Reynolds HN, Teiken P, Regan ME, et al. Hyperlactatemia, increased osmolar gap and renal dysfunction during continuous lorazepam infusion. Crit Care Med 2000; 28: 1631-4
9. Tobias JD. Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 2005; 34: 636-45
10. Coté CJ, Karl HW, Notterman DA, et al. Adverse sedation effects in pediatrics: analysis of medications used for sedation. Pediatrics 2000; 106: 633-44
11. Bray RJ. Fatal myocardial failure associated with a propofol infusion in a child. Anaesthesia 1995; 50: 94
12. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-6
13. Stickland RA, Murray MJ. Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship? Crit Care Med 1995; 23: 405-9
14. Bhana NL, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-8
15. Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004; 97 (5): 451-5
16. Tobias JD, Berkenbosch JW. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 2003; 4 (2): 203-5
17. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002; 12 (2): 171-5
18. Hammer GB, Philip BM, Schroeder AR, et al. Prolonged infusion of dexmedetomidine for sedation following tracheal resection. Paediatr Anaesth 2005; 15: 616-20
19. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine tomidine in pediatric patients. South Med J 2003; 96 (9): 871-5
20. Enomoto Y, Kudo T, Saito T, et al. Prolonged use of dexmedetomidine in an infant with respiratory failure following liver donor liver transplantation. Pediatr Anesth 2006; 16: 1285-8
21. Tobias JD. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag 2006; 2: 201-5
22. Finkel JC, Elrefai A. The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification of an infant. Anesth Analg 2004; 98: 1658-9
23. Finkel JC, Quezado ZMN. Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J Clin Anesth 2007; 19: 290-2
24. Walker J, MacCallum M, Fisher C, et al. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006; 27: 206-10
25. Mukhtar AM, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg 2006; 103: 52-6
26. Chrysostomou C, Zeballos T. Use of dexmedetomidine in a pediatric heart transplant patient. Pediatr Cardiol 2005; 26: 651-4
27. Chrysostomou C, Di Filippo S, Manrique A, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 2006; 7: 126-31
28. Finkel JC, Johnson YJ, Quezado ZMN. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005; 33: 2110-2
29. Baddingam K, Russo O, Russo J, et al. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005; 20: 118-23
30. Koroglu A, Demirbilek S, Tekan H, et al. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005; 94: 821-4
31. Koroglu A, Teskan H, Sagir O, et al. A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg 2006; 103: 63-7
32. Mason KP, Zgleszewski SE, Dearden JL, et al. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg 2006; 103: 57-62
33. Berkenbosch JW, Wankum PC, Tobias JD. Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pediatr Crit Care Med 2005; 6: 435-9
34. Nichols DP, Berkenbosch JW, Tobias JD. Rescue sedation with dexmedetomidine for diagnostic imaging: a preliminary report. Pediatr Anesth 2005; 15: 199-203
35. Luscri N, Tobias JD. Monitored anesthesia care with a combination of ketamine and dexmedetomidine during magnetic resonance imaging in three children with trisomy 21 and obstructive sleep apnea. Pediatr Anesth 2006; 16: 782-6
36. Shukry M, Ramadhyani U. Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21 month old child. Pediatr Anesth 2005; 15: 241-2
37. Young ET. Dexmedetomidine sedation in a pediatric cardiac patient scheduled for MRI. Can J Anesth 2005; 52: 730-2
38. Heard CMB, Joshi P, Johnson K. Dexmedetomidine for pediatric MRI sedation: a review of a series of cases. Pediatr Anesth 2007; 17: 888-92
39. Ibacache ME, Munoz HR, Brandes V, et al. Single dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children. Anesth Analg 2004; 98: 60-3
40. Guler G, Akin A, Tosun Z, et al. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonstillectomy. Pediatr Anesth 2005; 15: 762-6
41. Isik B, Arslan M, Tunga AD, et al. Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery. Pediatr Anesth 2006; 16: 748-53
42. Shukry M, Clyde MC, Kalarickal PL, et al. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Pediatr Anesth 2005; 15: 1098-104
43. Rosen DA, Daume JT. Short duration large dose dexmedetomidine in a pediatric patient during procedural sedation. Anesth Analg 2006; 103: 68-9
44. Easley RB, Brady KM, Tobias JD. Dexmedetomidine for the treatment of postanesthesia shivering in children. Pediatr Anesth 2007; 17: 341-6
45. Zub D, Berkenbosch JW, Tobias JD. Preliminary experience with oral dexmedetomidine for procedural and anesthetic premedication. Pediatr Anesth 2005; 15: 932-8
46. Schmidt AP, Valinetti EA, Bandeira DB, et al. Effects of preanesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in children. Pediatr Anesth 2007; 17: 667-74
47. Deutsch E, Tobias JD. and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs. desflurane. Pediatr Anesth 2007; 17: 438-44
48. Shurky M, Kennedy K. Dexmedetomidine as a total intravenous anesthetic in infants. Pediatr Anesth 2007; 17: 581-3
49. Ard J, Doyle W, Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 2003; 15: 263-6
50. Everett LL, Van Rooyen IF, Warner MH, et al. Use of dexmedetomidine in awake craniotomy in adolescents: report of two cases. Pediatr Anesth 2006; 16: 338-42
51. Tosun Z, Akin A, Guler G, et al. Dexmedetomidine-ketamine and propofol-ketamine combinations for anesthesia in spontaneously breathing pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2006; 20: 515-9
52. Munro HM, Tirotta CF, Felix DE, et al. Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Pediatr Anesth 2007; 17: 109-12
53. Khasawinah TA, Ramirez A, Berkenbosch JW, et al. Preliminary experience with dexmedetomidine in the treatment of cyclic vomiting syndrome. Am J Ther 2003; 10: 303-7
54. Gertler R, Brown HC, Mitchell DH, et al. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 2001; 14: 13-21
55. Precedex® (dexmedetomidine) [manufacturer package insert]. Lake Forest (IL): Hospira© Inc., 2004
56. Rodarte A, Diaz SM, Foley J, et al. The pharmacokinetics of dexmedetomidine in post-surgical pediatric intensive care unit patients: a preliminary study [abstract]. Anesthesiology 2003; 99: A423
57. Peyroz GC, Sikich N, James M, et al. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006; 105: 1098-110
58. Taghon TA, Bryan YF, Kurth CD. Pediatric radiology sedation and anesthesia. Int Anesthsiol Clin 2006; 44: 65-79
59. Boswinkel JP, Litman RS. Sedating patients for radiologic studies. Pediatr Ann 2005; 34: 650-6
60. Pershad J, Gilmore B. Successful implementation of a radiology sedation service staffed exclusively by pediatric emergency physicians. Pediatrics 2006; 117: 413-22
61. Ravelli AM. Cyclic vomiting syndrome. J Pediatr Gastroenterol 1995; 32: S14-5